Cancer drug target is promising lead for new TB treatments

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis, according to a new study. The human equivalent of this enzyme has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies. Scientists have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.

Read the whole article on Science Daily

More from Science Daily